Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
about
Therapy related leukemias: susceptibility, prevention and treatment.Second cancers in survivors of childhood cancer.Hodgkin's Lymphoma in Children and Adolescents: A Saint Petersburg Hodgkin's Lymphoma Group StudySecondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and AdolescenceSecond malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.Myelodysplastic Syndrome Occurring in a Patient with Gorlin Syndrome.Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.International note: second malignant neoplasms in children: a multicenter study of the Polish Pediatric Leukemia/Lymphoma Group.
P2860
Q34265193-BC84F69A-0A39-4D3E-8F44-54635D0DA519Q35084794-A26E8FAF-946C-4FBA-8FA7-B83FAFA8A39CQ35104961-49248882-1376-434C-81D6-B03F22504218Q35682335-CEA1BEFB-B80A-42C4-9962-3B962039D814Q36915223-F3F098C5-5C54-435F-BCBF-383F6C78E62EQ37078647-06A33E95-B09B-45C2-ACC8-3215E6B7E5E3Q37207597-C1255E0A-63A8-4AF7-BE78-989F6FA3BEB3Q37346340-A4623FCA-9187-4DC1-8489-C28E92A4CA52Q37627536-025912FC-279C-4128-A823-BA84C8067483Q42493977-C2C349A3-A103-426D-BFAB-E3EA472C4A62Q44051866-41EFF050-F425-4632-9756-FD28F1A74CAFQ44212690-FAA239B6-732D-4D33-928B-5E58008904BCQ53315385-FC0F1C61-BE30-4D05-BBBB-2323FF3C6DCB
P2860
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@en
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@nl
type
label
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@en
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@nl
prefLabel
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@en
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@nl
P2093
P1476
Low risk of secondary leukemia ...... atric Hodgkin's Disease Group.
@en
P2093
G Schellong
M Riepenhausen
U Creutzig
P304
P356
10.1200/JCO.1997.15.6.2247
P407
P577
1997-06-01T00:00:00Z